tykhr
sign in
free sign up
Eiger Biopharmaceuticals Inc
Biotechnology
Healthcare
EIGR
44.01 M shares
NASDAQ US
traded
09 Mar 2023
listed
yes
open
1.54
52 week high
9.74
high
1.54
52 week low
1.32
low
1.34
growth
-82.95 %
previous Close
1.54
P/E ratio
market cap
60.60 M
div yield
0
usd
Sep 2022
qoq
revenue
4.02 M
-1.64 %
net incoming
-27.11 M
-23.89 %
eps
0.00 %
-21.57 %
eps surprise
-19.23 %
net profit margin
-673.73 %
-138.00 %
operating incoming
-26.37 M
-31.32 %
net change in cash
-10.26 M
-2.74 %
cash on hand
26.31 M
-28.07 %
cost of revenue
1.23 M
715.23 %
top